S. Mavroukakis

发表

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

M. Raffeld, P. Duray, S. Rosenberg, 2002, Science.

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

S. Rosenberg, R. Morgan, J. Yang, 2006, Science.

Tumor Progression Can Occur despite the Induction of Very High Levels of Self/Tumor Antigen-Specific CD8+ T Cells in Patients with Melanoma

S. Steinberg, S. Rosenberg, J. Yang, 2005, The Journal of Immunology.

A Phase I Study of Nonmyeloablative Chemotherapy and Adoptive Transfer of Autologous Tumor Antigen-Specific T Lymphocytes in Patients With Metastatic Melanoma

F. Marincola, S. Rosenberg, P. Hwu, 2002, Journal of immunotherapy.

Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.

S. Rosenberg, P. Hwu, J. Yang, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

S. Rosenberg, J. Yang, A. Maker, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunization of Patients with Metastatic Melanoma Using Both Class I- and Class II-Restricted Peptides from Melanoma-Associated Antigens

S. Rosenberg, P. Hwu, J. Yang, 2003, Journal of immunotherapy.

Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen.

S. Rosenberg, P. Hwu, J. Yang, 2003, Human gene therapy.

Immunization of HLA-A*0201 and/or HLA-DPβ1*04 Patients with Metastatic Melanoma Using Epitopes from the NY-ESO-1 Antigen

S. Rosenberg, J. Yang, S. Topalian, 2004, Journal of immunotherapy.

Study on Adoptive Immunotherapy Using Gene-Modified TCells for Ovarian Cancer

S. Rosenberg, P. Hwu, S. Canevari, 2006 .

Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

S. Rosenberg, I. Lowy, J. Yang, 2007, Journal of immunotherapy.

Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study

S. Rosenberg, J. Yang, A. Maker, 2005, Annals of Surgical Oncology.

Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal Cancer

M. Morse, N. Azad, S. Mavroukakis, 2020, Clinical Cancer Research.

Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas

S. Mavroukakis, C. Annunziata, K. Tsang, 2022, Cancers.

VivoPartial Reduction in Regulatory T Cells In Metastatic Melanoma Induces a Selective Immunotoxin, LMB-2, to Patients with Administration of a CD25-Directed

I. Pastan, M. Merino, S. Rosenberg, 2007 .

Administration of a CD25-Directed Immunotoxin, LMB-2, to Patients with Metastatic Melanoma Induces a Selective Partial Reduction in Regulatory T Cells In Vivo1

I. Pastan, M. Merino, S. Rosenberg, 2007, The Journal of Immunology.

Viruses Encoding the Anchor-modified gp 100 Melanoma Antigen Can Generate Antitumor Immune Responses in Patients with Metastatic Melanoma

S. Rosenberg, P. Hwu, J. Yang, 2003 .

IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells

S. Rosenberg, M. Stetler-Stevenson, T. Fry, 2006, Journal of immunotherapy.

Phase I Trial Using CD19/CD22 Bispecific CAR T Cells in Pediatric and Adult Acute Lymphoblastic Leukemia (ALL)

K. Davis, K. Kong, D. Miklos, 2019, Blood.

Phase 1 Study of CD19/CD22 Bispecific Chimeric Antigen Receptor (CAR) Therapy in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia (ALL)

K. Davis, K. Kong, D. Miklos, 2018, Blood.

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

S. Rosenberg, J. Yang, S. Topalian, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effect of Nystatin on the Development of Oral Irritation in Patients Receiving High-Dose Intravenous Interleukin-2

S. Steinberg, F. Marincola, S. Rosenberg, 2001, Journal of immunotherapy.

Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201

S. Mavroukakis, C. Annunziata, K. Tsang, 2022, Cancers.

Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma

J. Lacy, B. Wolpin, M. Morse, 2023, JAMA network open.

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Thomas A. Davis, Steven A. Rosenberg, Douglas J. Schwartzentruber, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

John Mao, Francesco M Marincola, F. Marincola, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas

Christina M. Annunziata, S. Mavroukakis, C. Annunziata, 2018, Front. Immunol..

A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancer

M. Morse, S. Patel, N. Azad, 2016, Cancer Chemotherapy and Pharmacology.

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

Gang Wang, Steven A. Rosenberg, Zelig Eshhar, 2006, Clinical Cancer Research.

Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma

S. Rosenberg, J. Yang, A. Maker, 2006, Journal of immunotherapy.

Evaluation of Prime/Boost Regimens Using Recombinant Poxvirus/Tyrosinase Vaccines for the Treatment of Patients with Metastatic Melanoma

S. Steinberg, S. Rosenberg, M. Gonzales, 2006, Clinical Cancer Research.

Phase I Experience with a Bi-Specific CAR Targeting CD19 and CD22 in Adults with B-Cell Malignancies

Yasodha Natkunam, Matthew J. Frank, Y. Natkunam, 2018, Blood.

Altered CD8+ T-Cell Responses When Immunizing With Multiepitope Peptide Vaccines

S. Rosenberg, J. Yang, S. Topalian, 2006, Journal of immunotherapy.

Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibody.

S. Rosenberg, S. Mavroukakis, F. Smith, 2007, Journal of immunotherapy.

First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors

S. Lipkowitz, Jung-Min Lee, P. Fetsch, 2023, Journal of Experimental & Clinical Cancer Research.

Clinical pathways for managing patients receiving interleukin 2.

D. Schwartzentruber, R. White, S. Mavroukakis, 2001, Clinical journal of oncology nursing.

Phase I S tudy o f t he I ntravenous A dministration o f Attenuated Salmonella t yphimurium to P atients W ith Metastatic M elanoma

F. Marincola, S. Rosenberg, P. Hwu, 2002 .